相似化合物
886365-02-2 886364-94-9 717843-45-3欧盟法规
ECHA物质C&L通报上下游产品
2-amino-5-bromo-4-methylpyridine 5-[2-chloro-4-hydroxy-5-(2,3,4,5-tetrahydro-benzo[b]azepine-1-sulfonyl)-phenyl]-4-methyl-pyridine-2-carbonitrile 4-chloro-3-(6-cyano-4-methyl-pyridin-3-yl)-N-(2-hydroxy-phenyl)-N-methyl-benzamide 1-(5-bromo-4-methyl-2-pyridyl)ethanone 5-bromo-2-[5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-4-methyl-pyridine 合成工艺路线路线简述
- 3430-26-0 = 886364-86-9
反应条件:1.1 Catalysts: Tetrakis(Triphenylphosphine)Palladium Solvents: Dimethylformamide; 5 Min,150 °C
标题:Discovery Of The S1P2 Antagonist Glpg2938 (1-[2-Ethoxy-6-(Trifluoromethyl)-4-Pyridyl]-3-[[5-Methyl-6-[1-Methyl-3-(Trifluoromethyl)Pyrazol-4-Yl]Pyridazin-3-Yl]Methyl]Urea),A Preclinical Candidate For The Treatment Of Idiopathic Pulmonary Fibrosis
作者:Mammoliti,Oscar; Palisse,Adeline; Joannesse,Caroline; El Bkassiny,Sandy; Allart,Brigitte; Et Al
参考文献:Journal Of Medicinal Chemistry 日期:2021 卷标:64(9) 页码:6037-6058
📜2,5-二溴-4-甲基吡啶置于正丁基锂,三氯氧磷体系中,用 甲苯,正戊烷 作为反应溶剂,化学反应 8.0H,反应生成 5-溴-4-甲基-2-氰基吡啶
参考文献:Wo2008/124610
标题:Wo2008/124610
专利信息
专利号:EP-3103803-B1
优先权日:2008-10-27
标 题 :Intermediates for the synthesis of mtor kinase inhibitors
专利号:EP-3660020-A1
优先权日:2008-10-27
标题 :Process for the synthesis of mtor kinase inhibitors
专利号:ES-2794012-T3
优先权日:2008-10-27
标题 :Intermediaries for the synthesis of mTOR kinase inhibitors
专利号:EP-3103803-A1
优先权日:2008-10-27
标 题 :Intermediates for the synthesis of mtor kinase inhibitors
专利号:EP-3660020-B1
优先权日:2008-10-27
标题:Process for the synthesis of mtor kinase inhibitors
专利号:EP-3091021-B1
优先权日:2009-10-26
标题:Methods of synthesis and purification of heteroaryl compounds